Powell’s speech, Nvidia’s chips, Meta deal - what’s moving markets
NEW YORK - USANA Health Sciences, Inc. (NYSE:USNA) reported mixed first quarter results, with revenue beating expectations but earnings per share falling short of analyst estimates.
The nutritional supplement company posted adjusted earnings per share of $0.73, missing the consensus estimate of $0.80. Revenue came in at $250 million, surpassing analyst projections of $243.15 million and representing 10% year-over-year growth.
USANA’s direct selling business saw net sales decline 6.9% year-over-year to $210.5 million. However, this was offset by $37.1 million in revenue from Hiya, the children’s health and wellness company USANA acquired a majority stake in last year.
"We are seeing encouraging signs in our direct sales business with net sales and Active Customers growing modestly on a sequential basis for the second consecutive quarter," said Jim Brown, President and CEO.
For fiscal year 2025, USANA reiterated its outlook, forecasting revenue of $920 million to $1 billion and adjusted EPS of $2.35 to $3.00. The midpoint of the revenue guidance range is slightly above the current analyst consensus of $941.6 million.
"While the global macroeconomic environment has become less certain since the beginning of the year due to volatility in international trade, tariffs, and consumer sentiment, the underlying demand for our products has remained strong," Brown added.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.